Miniaturized devices and pressures for increased patient convenience and lo
wered cost have shortened length of stay for coronary interventions.
A cohort of 60 patients was recruited to assess the feasibility of outpatie
nt stenting with vascular sealing. Patients with stable and unstable angina
or myocardial infarction > 24 hours were considered for this strategy.
Mean time to hemostasis, ambulation and discharge were 6.1, 256 and 296 min
utes, respectively, for the 6F group, and 11.0, 351 and 459 minutes for the
7 to 8F group. No acute procedural complications occurred, and there were
no ischemic complications at 24 hours or 1 month. There was 1 pseudoaneurys
m requiring surgical correction? but no other access site requiring treatme
nt. The cost saved using the 6F approach is estimated at $ 478 and using th
e SF approach, $ 437.
Outpatient stenting using vascular sealing is feasible and safe, and may le
ad to significant nationwide cost reductions in the range of $ 40,000,000 y
early.